N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor

European Journal of Pharmacology

Volumn 343, Issue 2-3, 1998, Pages 323-331

  Bouley, Richard ^a   Pérodin, Jacqueline ^a   Plante, Hendrick ^a   Řihakova, Lenka ^a   Bernier, Sylvie G ^a   Maletínská, Lenka ^a   Guillemette, Gaétan ^a   Escher, Emanuel ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Angiotensin AT1 receptor; Angiotensin AT2 receptor; Angiotensin II; Myometrium, human; Uterus

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN[1 SARCOSINE 8 GLYCINE]; ANGIOTENSIN[1 SARCOSINE]; ANGIOTENSIN[1-6]; ANGIOTENSIN[1-7]; L 163017; LOSARTAN; LOSARTAN POTASSIUM; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ACETYLATION; ADULT; ALKYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL MODIFICATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MYOMETRIUM; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

ANGIOTENSIN II; BINDING SITES; FEMALE; HUMANS; MYOMETRIUM; RECEPTORS, ANGIOTENSIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0344541092     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01549-5     Document Type: Article

References (42)

1. 2 receptors do not interact with guanine nucleotide binding proteins. Eur. J. Pharmacol. 207:1991;157-163.
2. Bouley R., Gosselin M., Plante H., Servant G., Pérondin J., Arcand M., Guillemette G., Escher E. Characterization of a specific binding site for angiotensin II in chicken liver. Can. J. Physiol. Pharmacol. 75:1997;568-575.
3. Bumpus F.M., Catt K.J., Chiu A.T., de Gasparo M., Goodfriend T., Husain A., Peach M.J., Taylor D.G., Timmermans P.B.M.W.M. Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension. 17:1991;720-723.
4. Chang R.S., Lotti V.J. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new non-peptide ligands. Mol. Pharmacol. 37:1990;347-351.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1978;3099-3108.
6. Chiu A.T., Herblin W.F., McCall D.E., Ardecky R.J., Carini D.J., Duncia J.V., Pease L.J., Wong P.C., Wexler R.R., Johnson A.L., Timmermans P.B.M.W.M. Identification of angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 165:1989;196-203.
7. Cox B.E., Word R.A., Rosenfeld C.R. Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy. J. Clin. Endocrinol. Metab. 81:1990;49-58.
8. Criscione L., Thomann H., Whitebread S., de Gasparo M., Bühlmayer P., Herold P., Ostermayer R., Kamber B. Binding characteristics and vascular effects of various angiotensin II antagonists. J. Cardiovasc. Pharmacol. 16 (Suppl. 4):1990;s56-s59.
9. 2) binding sites in R3T3 cells. Mol. Pharmacol. 40:1991;360-367.
10. Escher E., Nguyen T.D.M., Regoli D.C. Photoaffinity labeling of the angiotensin II receptor; Pharmacology of the labeling peptides in the dark. Can. J. Physiol. Pharmacol. 56:1978;956-962.
11. Escher E., Nguyen T.D.M., Robert H., St-Pierre S.A., Regoli D.C. Photoaffinity labeling of the angiotensin receptor. 1: Synthesis and biological activities of the labeling peptides. J. Med. Chem. 21:1978;860-864.
12. Escher E., Guillemette G., Leukart O., Regoli D. Pharmacological properties of two analogues of angiotensin II containing carboranylalanine (Car). Eur. J. Pharmacol. 66:1980;267-272.
13. Fraker P.J., Speck J.C. Protein and cell iodinations with a sparingly soluble chloroamine, 1,3,4,6-tetrachloro-3a,6a-diphenylglycouril. Biochem. Biophys. Res. Commun. 80:1978;849-857.
14. Furuta H., Guo D.F., Inagami T. Molecular cloning and sequencing of encoding human angiotensin II type 2. Biochem. Biophys. Res. Commun. 183:1992;8-13.
15. Guillemette G., Bernier M., Parent P., Leduc R., Escher E. Angiotensin II: Dependence of hormone affinity on the electronegativity of a single side chain. J. Med. Chem. 27:1984;315-320.
16. Hansch C., Leo A., Unger S.H., Kim K.H., Nikaitani D., Lien E.J. Aromatic substituent constants for structure-activity correlations. J. Med. Chem. 16:1973;1207-1216.
17. Höhle S., Culman J., Boser M., Qadri F., Unger T. Effect of angiotensin AT2 and muscarinic receptor blockade on osmotically induced vasopressin release. Eur. J. Pharmacol. 300:1996;119-123.
18. Hsieh K.H., Marshall G.R. Role of the C-terminal carboxylate in angiotensin II activity: Alcohol, ketone and ester analogues of angiotensin II. J. Med. Chem. 29:1986;1968-1971.
19. Kempf H., le Moullec J.M., Corvol P., Gasc J.M. Molecular cloning, expression and tissue distribution of a chicken angiotensin II receptor. FEBS Lett. 399:1996;198-202.
20. Lazard D., Villageois P., Briend-Sutren M.M., Cavaillé F., Bottari S., Strosberg A.D., Nahmias C. Characterization of a membrane glycoprotein having pharmacological and biochemical properties of an AT2 angiotensin II receptor from human myometrium. Eur. J. Biochem. 220:1994;919-926.
21. 2) binding sites in the rat pheochromocytoma PC12w cells. Eur. J. Pharmacol. 227:1992;63-70.
22. Levy B.I., Benessiano J., Henrion D., Caputo L., Heymes C., Duriez M., Poitevin P., Samuel J.L. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J. Clin. Invest. 98:1992;418-425.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. 1 receptor: Gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA. 92:1995;10663-10667.
25. Nio Y., Matsubara H., Murasawa S., Kanasaki M., Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infraction. J. Clin. Invest. 95:1995;46-54.
26. Nikiforovich G.V., Marshall G.R. Three-dimensional recognition requirements for angiotensin agonists: A novel solution for an old problem. Biochem. Biophys. Res. Commun. 195:1993;222-228.
27. Peach M.J. Molecular actions of angiotensin. Biochem. Pharmacol. 30:1981;2745-2751.
28. Pérodin, J., Bossé, R., Gagnon, S., Zhou, L.M., Bouley, R., Leduc, R. and Escher, E., 1996. Structure-activity relationship of the agonist-antagonist transition on the type 1 angiotensin II receptor: The search for inverse agonists. In: Raizada, M.K., Phillips, M.I., Summers, C. (Eds.), Recent Advances in Cellular and Molecular Aspects of angiotensin Receptors, vol. 358. Plenum Press, pp. 131-143.
29. Powell J.S., Müller M.R.K., Rouge M., Kuhn H., Hefti F., Baumgartner H.R. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J. Cardiovasc. Pharmacol. 16 (Suppl. 4):1990;S42-S49.
30. Pucell A.G., Hodges J.C., Sen I., Bumpus F.M., Husain A. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptors. Endocrinology. 128:1991;1947-1959.
31. Regoli D., Park W.K., Rioux F. Pharmacology of angiotensin. Pharmacol. Rev. 26:1974;69-123.
32. Servant G., Dudley D.T., Escher E., Guillemette G. The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation. Mol. Pharmacol. 45:1994;1112-1118.
33. 2 receptor with photolabile angiotensin analogues. J. Biol. Chem. 272:1997;8653-8659.
34. Timmermans P.B.M.W.M., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., Lee R.J., Wexler R.R., Saye J.A., Smith R.D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:1993;205-251.
35. Tsuzuki S., Ichiki T., Nakakubo H., Kitami Y., Guo D.F., Shirai H., Inagami T. Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor. Biochem. Biophys. Res. Commun. 200:1994;1449-1454.
36. Vallotton M.B. The renin-angiotensin system. Trends Pharmacol. Sci. 8:1987;69-74.
37. 2 receptors in the rat skin during experimental wound healing. Peptides. 13:1992;783-786.
38. Whitebread S., Mele M., Kamber B., de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163:1989;284-291.
39. Whitebread S., Pfeilschifter J., Ramjoué H., de Gasparo M. Angiotensin II binding sites on micro-organisms contaminating cell cultures. Regul. Peptides. 44:1993;233-238.
40. 2-receptor antagonists. Am. J. Physiol. 265:1993;H226-H231.
41. Yamada T., Horiuchi M., Dzau V.J. Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. USA. 93:1996;156-160.
42. 2 receptor subtype. Endocrinology. 137:1996;1204-1211.